{"count": 6, "results": [{"_id": "31149236", "pmid": 31149236, "title": "THE RISK OF COBALAMIN DEFICIENCY SYMPTOMS RELATED TO LONG-TERM METFORMIN USE IN T2DM PATIENTS.", "journal": "Acta Endocrinol (Buchar)", "authors": ["Hendrawati YD", "Andrajati R", "Supardi S", "Ariyani A"], "date": "2018-01-01T00:00:00Z", "doi": "10.4183/aeb.2018.49", "meta_date_publication": "2018 Jan-Mar", "meta_volume": "14", "meta_issue": "1", "meta_pages": "49-54", "score": 50060.266, "text_hl": "THE RISK OF @DISEASE_Methylmalonic_Aciduria_and_Homocystinuria_CblF_Type @DISEASE_MESH:C564747 @@@COBALAMIN DEFICIENCY@@@ @<m>DISEASE_Signs_and_Symptoms</m> @DISEASE_MESH:D012816 @@@SYMPTOMS@@@ RELATED TO @DISEASE_613485 @DISEASE_OMIM:613485 @@@LONG-TERM@@@ @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@METFORMIN@@@ USE IN T2DM PATIENTS.", "citations": {"NLM": "Hendrawati YD, Andrajati R, Supardi S, Ariyani A. THE RISK OF COBALAMIN DEFICIENCY SYMPTOMS RELATED TO LONG-TERM METFORMIN USE IN T2DM PATIENTS. Acta Endocrinol (Buchar). 2018 Jan-Mar;14(1):49-54. PMID: 31149236", "BibTeX": "@article{31149236, title={THE RISK OF COBALAMIN DEFICIENCY SYMPTOMS RELATED TO LONG-TERM METFORMIN USE IN T2DM PATIENTS.}, author={Hendrawati YD and Andrajati R and Supardi S and Ariyani A}, journal={Acta Endocrinol (Buchar)}, volume={14}, number={1}, pages={49-54}}"}}, {"_id": "18435670", "pmid": 18435670, "title": "Hypoglycaemia in patients with type 2 diabetes treated with a combination of metformin and sulphonylurea therapy in France.", "journal": "Diabetes Obes Metab", "authors": ["Vexiau P", "Mavros P", "Krishnarajah G", "Lyu R", "Yin D"], "date": "2008-06-01T00:00:00Z", "doi": "10.1111/j.1463-1326.2008.00883.x", "meta_date_publication": "2008 Jun", "meta_volume": "10 Suppl 1", "meta_issue": "", "meta_pages": "16-24", "score": 50055.78, "text_hl": "OBJECTIVE: To examine @SPECIES_9606 @@@patient@@@-reported experience of hypoglycaemia, worry about @<m>DISEASE_Signs_and_Symptoms</m> @DISEASE_MESH:D012816 @@@hypoglycaemic symptoms@@@ and the impact of hypoglycaemia on @SPECIES_9606 @@@patients@@@' quality of life associated with use of @CHEMICAL_Sulfonylurea_Compounds @CHEMICAL_MESH:D013453 @@@sulphonylurea@@@ co-administered with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@. ", "citations": {"NLM": "Vexiau P, Mavros P, Krishnarajah G, Lyu R, Yin D. Hypoglycaemia in patients with type 2 diabetes treated with a combination of metformin and sulphonylurea therapy in France. Diabetes Obes Metab. 2008 Jun;10 Suppl 1():16-24. PMID: 18435670", "BibTeX": "@article{18435670, title={Hypoglycaemia in patients with type 2 diabetes treated with a combination of metformin and sulphonylurea therapy in France.}, author={Vexiau P and Mavros P and Krishnarajah G and Lyu R and Yin D}, journal={Diabetes Obes Metab}, volume={10 Suppl 1}, pages={16-24}}"}}, {"_id": "12681024", "pmid": 12681024, "title": "Influence of initial hyperglycaemia, weight and age on the blood glucose lowering efficacy and incidence of hypoglycaemic symptoms with a single-tablet metformin-glibenclamide therapy (Glucovance) in type 2 diabetes.", "journal": "Diabetes Obes Metab", "authors": ["Garber A", "Marre M", "Blonde L", "Allavoine T", "Howlett H", "Lehert P", "Cornes M"], "date": "2003-05-01T00:00:00Z", "doi": "10.1046/j.1463-1326.2003.00259.x", "meta_date_publication": "2003 May", "meta_volume": "5", "meta_issue": "3", "meta_pages": "171-9", "score": 50052.258, "text_hl": "Influence of initial hyperglycaemia, weight and age on the @CHEMICAL_Blood_Glucose @CHEMICAL_MESH:D001786 @@@blood glucose@@@ lowering efficacy and incidence of @<m>DISEASE_Signs_and_Symptoms</m> @DISEASE_MESH:D012816 @@@hypoglycaemic symptoms@@@ with a single-tablet @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@-@CHEMICAL_Glyburide @CHEMICAL_MESH:D005905 @@@glibenclamide@@@ therapy (@CHEMICAL_Glucovance @CHEMICAL_MESH:C417231 @@@Glucovance@@@) in @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@type 2 diabetes@@@.", "citations": {"NLM": "Garber A, Marre M, Blonde L, Allavoine T, Howlett H, Lehert P, Cornes M. Influence of initial hyperglycaemia, weight and age on the blood glucose lowering efficacy and incidence of hypoglycaemic symptoms with a single-tablet metformin-glibenclamide therapy (Glucovance) in type 2 diabetes. Diabetes Obes Metab. 2003 May;5(3):171-9. PMID: 12681024", "BibTeX": "@article{12681024, title={Influence of initial hyperglycaemia, weight and age on the blood glucose lowering efficacy and incidence of hypoglycaemic symptoms with a single-tablet metformin-glibenclamide therapy (Glucovance) in type 2 diabetes.}, author={Garber A and Marre M and Blonde L and Allavoine T and Howlett H and Lehert P and Cornes M}, journal={Diabetes Obes Metab}, volume={5}, number={3}, pages={171-9}}"}}, {"_id": "18435671", "pmid": 18435671, "title": "Hypoglycaemic symptoms, treatment satisfaction, adherence and their associations with glycaemic goal in patients with type 2 diabetes mellitus: findings from the Real-Life Effectiveness and Care Patterns of Diabetes Management (RECAP-DM) Study.", "journal": "Diabetes Obes Metab", "authors": ["Alvarez Guisasola F", "Tofé Povedano S", "Krishnarajah G", "Lyu R", "Mavros P", "Yin D"], "date": "2008-06-01T00:00:00Z", "doi": "10.1111/j.1463-1326.2008.00882.x", "meta_date_publication": "2008 Jun", "meta_volume": "10 Suppl 1", "meta_issue": "", "meta_pages": "25-32", "score": 50047.316, "text_hl": "AIMS: This study was undertaken to evaluate (i) factors associated with @SPECIES_9606 @@@patient@@@-reported hypoglycaemia; (ii) association of @SPECIES_9606 @@@patient@@@-reported @<m>DISEASE_Signs_and_Symptoms</m> @DISEASE_MESH:D012816 @@@hypoglycaemic symptoms@@@ with treatment satisfaction and barriers to adherence and (iii) association between treatment satisfaction, adherence and glycaemic control among @SPECIES_9606 @@@patients@@@ with @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@type 2 diabetes@@@ who added a @CHEMICAL_Sulfonylurea_Compounds @CHEMICAL_MESH:D013453 @@@sulphonylurea@@@ or a @CHEMICAL_2_4_thiazolidinedione @CHEMICAL_MESH:C089946 @@@thiazolidinedione@@@ to ongoing @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@. ", "citations": {"NLM": "Alvarez Guisasola F, Tofé Povedano S, Krishnarajah G, Lyu R, Mavros P, Yin D. Hypoglycaemic symptoms, treatment satisfaction, adherence and their associations with glycaemic goal in patients with type 2 diabetes mellitus: findings from the Real-Life Effectiveness and Care Patterns of Diabetes Management (RECAP-DM) Study. Diabetes Obes Metab. 2008 Jun;10 Suppl 1():25-32. PMID: 18435671", "BibTeX": "@article{18435671, title={Hypoglycaemic symptoms, treatment satisfaction, adherence and their associations with glycaemic goal in patients with type 2 diabetes mellitus: findings from the Real-Life Effectiveness and Care Patterns of Diabetes Management (RECAP-DM) Study.}, author={Alvarez Guisasola F and Tofé Povedano S and Krishnarajah G and Lyu R and Mavros P and Yin D}, journal={Diabetes Obes Metab}, volume={10 Suppl 1}, pages={25-32}}"}}, {"_id": "15529514", "pmid": 15529514, "title": "Durable efficacy of metformin/glibenclamide combination tablets (Glucovance) during 52 weeks of open-label treatment in type 2 diabetic patients with hyperglycaemia despite previous sulphonylurea monotherapy.", "journal": "Int J Clin Pract", "authors": ["Blonde L", "Joyal S", "Henry D", "Howlett H"], "date": "2004-09-01T00:00:00Z", "doi": "10.1111/j.1742-1241.2004.00316.x", "meta_date_publication": "2004 Sep", "meta_volume": "58", "meta_issue": "9", "meta_pages": "820-6", "score": 50042.5, "text_hl": "The combination tablets were well tolerated: 11.1% of @SPECIES_9606 @@@patients@@@ reported @<m>DISEASE_Signs_and_Symptoms</m> @DISEASE_MESH:D012816 @@@hypoglycaemic symptoms@@@ (all either mild or moderate severity). ", "citations": {"NLM": "Blonde L, Joyal S, Henry D, Howlett H. Durable efficacy of metformin/glibenclamide combination tablets (Glucovance) during 52 weeks of open-label treatment in type 2 diabetic patients with hyperglycaemia despite previous sulphonylurea monotherapy. Int J Clin Pract. 2004 Sep;58(9):820-6. PMID: 15529514", "BibTeX": "@article{15529514, title={Durable efficacy of metformin/glibenclamide combination tablets (Glucovance) during 52 weeks of open-label treatment in type 2 diabetic patients with hyperglycaemia despite previous sulphonylurea monotherapy.}, author={Blonde L and Joyal S and Henry D and Howlett H}, journal={Int J Clin Pract}, volume={58}, number={9}, pages={820-6}}"}}, {"_id": "9585394", "pmid": 9585394, "title": "UKPDS 26: Sulphonylurea failure in non-insulin-dependent diabetic patients over six years. UK Prospective Diabetes Study (UKPDS) Group.", "journal": "Diabet Med", "authors": ["Matthews DR", "Cull CA", "Stratton IM", "Holman RR", "Turner RC"], "date": "1998-04-01T00:00:00Z", "doi": "10.1002/(SICI)1096-9136(199804)15:4<297::AID-DIA572>3.0.CO;2-W", "meta_date_publication": "1998 Apr", "meta_volume": "15", "meta_issue": "4", "meta_pages": "297-303", "score": 50026.543, "text_hl": "If their fasting plasma @CHEMICAL_Glucose @CHEMICAL_MESH:D005947 @@@glucose@@@ subsequently rose above 15.0 mmol l(-1), or they developed @<m>DISEASE_Signs_and_Symptoms</m> @DISEASE_MESH:D012816 @@@hyperglycaemic symptoms@@@, additional hypoglycaemic therapy was given: @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@, ultratard @GENE_INS @GENE_3630 @@@insulin@@@, and soluble @GENE_INS @GENE_3630 @@@insulin@@@ as required. ", "citations": {"NLM": "Matthews DR, Cull CA, Stratton IM, Holman RR, Turner RC. UKPDS 26: Sulphonylurea failure in non-insulin-dependent diabetic patients over six years. UK Prospective Diabetes Study (UKPDS) Group. Diabet Med. 1998 Apr;15(4):297-303. PMID: 9585394", "BibTeX": "@article{9585394, title={UKPDS 26: Sulphonylurea failure in non-insulin-dependent diabetic patients over six years. UK Prospective Diabetes Study (UKPDS) Group.}, author={Matthews DR and Cull CA and Stratton IM and Holman RR and Turner RC}, journal={Diabet Med}, volume={15}, number={4}, pages={297-303}}"}}]}